Soliris Alternatives Compared
| Soliris | Mestinon | Pyridostigmine |
|
|---|
| Soliris eculizumab | Mestinon pyridostigmine | Pyridostigmine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Myasthenia Gravis, Hemolytic Uremic Syndrome, Neuromyelitis Optica, Paroxysmal Nocturnal Hemoglobinuria. Soliris may also be used for purposes not listed in this medication guide. |
Prescribed for Myasthenia Gravis, Reversal of Nondepolarizing Muscle Relaxants, Nerve Agent Pretreatment. May also be prescribed off label for Dysautonomia. |
Prescribed for Myasthenia Gravis, Reversal of Nondepolarizing Muscle Relaxants, Nerve Agent Pretreatment. May also be prescribed off label for Dysautonomia. |
Choose a suggestion below Myasthenia Gravis
Popular Comparisons
|
|||||||||||||||||||||||
| More about Soliris (eculizumab) | More about Mestinon (pyridostigmine) | More about Pyridostigmine | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Soliris has an average rating of 5.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Mestinon has an average rating of 6.3 out of 10 from a total of 28 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 30% reported a negative effect. |
Pyridostigmine has an average rating of 6.9 out of 10 from a total of 41 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See the full Soliris side effects document. |
See the full Mestinon side effects document. |
See the full pyridostigmine side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Soliris prices |
View all Mestinon prices and generic prices |
View all pyridostigmine prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other pyridostigmine brands include: Mestinon Timespan, Regonol | Mestinon, Mestinon Timespan, Regonol | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
354 hours |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 5 drugs are known to interact with Soliris:
|
A total of 72 drugs are known to interact with Mestinon:
|
A total of 72 drugs are known to interact with pyridostigmine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 16, 2007 |
April 06, 1955 |
April 06, 1955 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.